Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P200020/S013

ClearView HD intraocular lens (IOL)

Lenstec, Inc. · Decision date Oct 23, 2026

MEDTECHLEDGER EXPLANATIONP200020/S013

What did the FDA approve?

The FDA recorded an approval decision on 2026-10-23 for P200020/S013, a supplement to the ClearView™ HD intraocular lens (IOL) held by Lenstec, Inc. The supplement was filed under the Normal 180 Day Track with the stated reason Change Design/Components/Specifications/Material, and the device sits in the multifocal intraocular lens category (product code MFK) within the ophthalmic specialty.

The recorded statement describes the supplement as covering the ClearView™ HD IOL as a combination of the haptic design of the ClearView™ 3 IOL with the optical design of the Softec HD IOL. That describes a design change to the lens rather than a new approval of an entire system. The source record does not include supporting documents, so the specific optical or haptic parameters changed, and any clinical data reviewed, remain unknown.

FDA approval order statement

approval for the ClearView HD Intraocular Lens (IOL) as a combination of the haptic design of the ClearView 3 IOL with the optical design of the Softec HD IOL
Regulatory pathway
PMA supplement
Supplement type
Normal 180 Day Track
Clinical specialty
Ophthalmic
Decision date
Oct 23, 2026
FDA change category
Change Design/Components/Specifications/Material

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P200020/S013
Regulatory pathway
PMA supplement
Applicant
Lenstec, Inc.
Product code
MFK
Decision code
APPR
Decision date
Oct 23, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Lens, multifocal intraocular.

Applicant
Lenstec, Inc.
Product code
MFK
FDA device class
3

For the original device and its historical approval scope, see PMA P200020. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P200020 · Original PMA

    SBL-3 Multifocal Intraocular Lens

  2. P200020/S013 received

    Application receipt date recorded by FDA.

  3. P200020/S013 · FDA decision

    Normal 180 Day Track

Timeline entries are records held by MedtechLedger for P200020. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P200020

Product / regulatory recordCompanyPathwayDecision dateSource
Lenstec, Inc.PMA approvalJul 22, 2022FDA

Explore the linked device profile

Other records with product code MFK

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Lenstec, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
1765 Commerce Ave. N, St. Petersburg, FL, 33716

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records